Inspire Medical Systems, Inc.·Healthcare

INSP gains from Inspire V gains traction, strong demand and margin gains boost results, but reimbursement shifts and WISeR rollout weigh on near-term outlook.

MINNEAPOLIS, April 06, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2026 after the close of trading on Monday, May 4. Inspire's management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

Top-ranked stocks INSP, SIMO, GWRE and ALL are likely to beat on the bottom line in their upcoming releases.

Inspire (INSP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Investors interested in Medical Info Systems stocks are likely familiar with Inspire Medical Systems (INSP) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks offers value investors a better bang for their buck right now?

STRT, DXPE, ASTE, OPRX and INSP have been added to the Zacks Rank #1 (Strong Buy) List on March 24, 2026.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Healthcare
Medical - Devices
1,246
2018-05-03
0.86